PDCD1 and colorectal carcinoma: This study aims to perform a complete deep omics molecular investigation of a CRC case in order to reveal specific alterations, which could help elucidating the underlying mechanisms of immune response and susceptibility to PD‐1/PD‐L1 blockade.